cADPR is a gene dosage-sensitive biomarker of SARM1 activity in healthy, compromised, and degenerating axons
Yo Sasaki(SHOWA Medical University), Aaron DiAntonio(Washington University in St. Louis), Todd Bosanac(Eli Lilly (United States)), Thomas M. Engber, Robert Hughes(Scripps Research Institute), Rajesh Devraj, Tong Wu(Washington University in St. Louis), Jeffrey Milbrandt(James S. McDonnell Foundation), Raul Krauss(Eli Lilly (United States)), Matthew D. Figley(Washington University in St. Louis)
Cited by 126
Related Papers
Increased Nuclear NAD Biosynthesis and SIRT1 Activation Prevent Axonal Degeneration
|Science|2004|1.1k
AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1
|Nature Genetics|2000|950
Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice
|Cell Metabolism|2016|900
Nampt/PBEF/Visfatin Regulates Insulin Secretion in β Cells as a Systemic NAD Biosynthetic Enzyme
|Cell Metabolism|2007|899